GB1001661A - Steroids and their preparation - Google Patents
Steroids and their preparationInfo
- Publication number
- GB1001661A GB1001661A GB36759/61A GB3675961A GB1001661A GB 1001661 A GB1001661 A GB 1001661A GB 36759/61 A GB36759/61 A GB 36759/61A GB 3675961 A GB3675961 A GB 3675961A GB 1001661 A GB1001661 A GB 1001661A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydroxy
- compound
- double bond
- keto
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003431 steroids Chemical class 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000000468 ketone group Chemical group 0.000 abstract 3
- -1 phosphoryl group Chemical group 0.000 abstract 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 abstract 2
- SUPOKHOQAKXOHJ-BYZMTCBYSA-N (8s,9s,10r,13r,14s,17s)-17-ethyl-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 SUPOKHOQAKXOHJ-BYZMTCBYSA-N 0.000 abstract 1
- LGTNVTBMTQCJMS-BYZMTCBYSA-N (8s,9s,10r,13r,14s,17s)-17-ethyl-10,13-dimethyl-2,3,8,9,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1=CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 LGTNVTBMTQCJMS-BYZMTCBYSA-N 0.000 abstract 1
- WILIRDQOEMCACO-BYZMTCBYSA-N (8s,9s,10r,13r,14s,17s)-17-ethyl-10,13-dimethyl-8,9,11,12,14,15,16,17-octahydro-3h-cyclopenta[a]phenanthrene Chemical compound C1=CC2=CCC=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](CC)[C@@]1(C)CC2 WILIRDQOEMCACO-BYZMTCBYSA-N 0.000 abstract 1
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 abstract 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 abstract 1
- 229910021554 Chromium(II) chloride Inorganic materials 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 229930194542 Keto Chemical group 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052788 barium Inorganic materials 0.000 abstract 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- XBWRJSSJWDOUSJ-UHFFFAOYSA-L chromium(ii) chloride Chemical compound Cl[Cr]Cl XBWRJSSJWDOUSJ-UHFFFAOYSA-L 0.000 abstract 1
- 229940109126 chromous chloride Drugs 0.000 abstract 1
- 229910052736 halogen Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 230000000865 phosphorylative effect Effects 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 150000004053 quinones Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000004332 silver Substances 0.000 abstract 1
- BOYYFZLRUNZGFW-UHFFFAOYSA-M silver;dihydrogen phosphate Chemical compound [Ag+].OP(O)([O-])=O BOYYFZLRUNZGFW-UHFFFAOYSA-M 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6349760A | 1960-10-19 | 1960-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1001661A true GB1001661A (en) | 1965-08-18 |
Family
ID=22049605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB36759/61A Expired GB1001661A (en) | 1960-10-19 | 1961-10-13 | Steroids and their preparation |
Country Status (8)
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1033199B (de) * | 1955-06-08 | 1958-07-03 | Organon Nv | Verfahren zur Darstellung von Dehydrosteroiden |
| US2891079A (en) * | 1959-01-23 | 1959-06-16 | Searle & Co | 6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof |
-
1961
- 1961-10-11 DE DEM50554A patent/DE1246728B/de active Pending
- 1961-10-13 GB GB36759/61A patent/GB1001661A/en not_active Expired
- 1961-10-17 ES ES0272044A patent/ES272044A1/es not_active Expired
- 1961-10-18 DK DK369462AA patent/DK105021C/da active
- 1961-10-18 DK DK369562AA patent/DK108572C/da active
- 1961-10-18 SE SE10354/61A patent/SE302120B/xx unknown
- 1961-10-19 BE BE609377A patent/BE609377A/fr unknown
- 1961-10-19 CH CH1209161A patent/CH413832A/de unknown
-
1962
- 1962-01-17 FR FR885094A patent/FR2145M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK108572C (da) | 1968-01-08 |
| BE609377A (fr) | 1962-02-15 |
| FR2145M (fr) | 1963-11-18 |
| DK105021C (da) | 1966-08-08 |
| CH413832A (de) | 1966-05-31 |
| ES272044A1 (es) | 1962-03-16 |
| SE302120B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1968-07-08 |
| DE1246728B (de) | 1967-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1438940A (en) | 17beta-haloalkoxycarbonyl-17alpha-oxysteroids | |
| GB1001661A (en) | Steroids and their preparation | |
| KR900014422A (ko) | 신규 스테로이드 디올과 이들을 함유하는 약제학적 조성물 및 이들의 제조방법 | |
| GB989881A (en) | Improvements in or relating to 10 -methyl steroids and the production thereof | |
| GB1103987A (en) | The preparation of des-a-steroids | |
| GB997380A (en) | Synthesis of steroids | |
| GB843215A (en) | Improvements in or relating to steroid compounds | |
| AU523501B2 (en) | 21 hydroxy 20 oxo 17 alpha pregnanes | |
| GB1196683A (en) | Improvements in or relating to 6,7-Dihalomethylene Steroids | |
| US2988557A (en) | 16alpha-thiol corticoids and their derivatives | |
| GB940274A (en) | Synthesis of steroids | |
| US2892850A (en) | 21-chloro steroids | |
| GB1036276A (en) | 7,16-dialkyl-pregnanes | |
| GB1119083A (en) | New steroids | |
| US2982768A (en) | 16beta-lower alkyl pregnane derivatives | |
| GB990365A (en) | Cyclopenteno derivatives of the androstene, ª‡-androstane and ª‰-androstane series and process for their manufacture | |
| GB826365A (en) | Steroid compounds | |
| GB810859A (en) | Improvements in or relating to steroids and the manufacture thereof | |
| GB949843A (en) | Cyclopentanophenanthrene derivatives and process for their preparation | |
| GB1173960A (en) | Unsaturated Lactones of the Steroid Series and Process for their Manufacture | |
| GB994747A (en) | 19-oxygenated steroids and process for their manufacture | |
| GB984839A (en) | Steroid compounds | |
| GB744241A (en) | Manufacture of new esters of 20:21-ketols of the pregnene series | |
| SE335855B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| GB890565A (en) | 3-keto-4-pregnenes and method of preparation |